Leading the Way in Life Science Technologies

GEN Exclusives

More »

Columns

More »

For full access to this article login to GEN Select now.

Aug 1, 2014 (Vol. 34, No. 14)

FDA Gets Social with Biopharmas

Much to “Like” in Draft Guidance on Misinformation, But Not on Limited-Space Forums

  • Despite all the hype about its transforming business relationships, half of the top 50 pharmaceutical companies make no use of social media, according to ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.
    •  


Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »